TCL Archive DeVita Suggest Chop Should Be Expanded, Given Long Term Status, But Only With A “Quid Pro Quo” March 20, 1981
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s. February 25, 2000
